|
WO2013036835A1
(en)
|
2011-09-08 |
2013-03-14 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
CN113234114A
(zh)
|
2011-10-14 |
2021-08-10 |
萨奇治疗股份有限公司 |
3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
|
|
CA2862076C
(en)
|
2012-01-23 |
2020-04-21 |
Sage Therapeutics, Inc. |
Neuroactive steroid formulations and methods of treating cns disorders
|
|
PL2887944T3
(pl)
|
2012-08-21 |
2022-02-21 |
Sage Therapeutics, Inc. |
Allopregnanolon do leczenia lekoopornego stanu padaczkowego
|
|
JP2016501876A
(ja)
|
2012-11-30 |
2016-01-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ステロイドの抗痙攣活性
|
|
RS67266B1
(sr)
|
2013-03-13 |
2025-10-31 |
Sage Therapeutics Inc |
Neuroaktivni steroidi i postupci za njihovu upotrebu
|
|
WO2014169836A1
(en)
|
2013-04-17 |
2014-10-23 |
Sage Therapeutics, Inc. |
19-nor neuroactive steroids and methods of use thereof
|
|
MX362543B
(es)
|
2013-04-17 |
2019-01-24 |
Sage Therapeutics Inc |
Esteroides c21-n-pirazolilo 19-nor c3,3- disustituidos y metodos de uso de los mismos.
|
|
WO2014169831A1
(en)
|
2013-04-17 |
2014-10-23 |
Sage Therapeutics, Inc. |
19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
|
|
WO2014169832A1
(en)
|
2013-04-17 |
2014-10-23 |
Sage Therapeutics, Inc. |
19-nor neuroactive steroids and methods of use thereof
|
|
HRP20210610T1
(hr)
|
2013-07-19 |
2021-05-28 |
Sage Therapeutics, Inc. |
Neuroaktivni steroidi, pripravci i njihove uporabe
|
|
PT3035940T
(pt)
|
2013-08-23 |
2019-01-28 |
Sage Therapeutics Inc |
Esteroides neuroativos, composições e seus usos
|
|
WO2015195962A1
(en)
|
2014-06-18 |
2015-12-23 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
WO2015195967A1
(en)
|
2014-06-18 |
2015-12-23 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
US10172870B2
(en)
|
2014-09-02 |
2019-01-08 |
The Texas A&M University System |
Method of treating organophosphate intoxication by administration of neurosteroids
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
EP3885352B1
(en)
|
2014-10-16 |
2024-11-27 |
Sage Therapeutics, Inc. |
A compound, compositions thereof and this compound for use in methods of treating cns disorders
|
|
EP4275748A3
(en)
|
2014-10-16 |
2024-01-03 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
RS60343B1
(sr)
|
2014-11-27 |
2020-07-31 |
Sage Therapeutics Inc |
Kompozicije i postupci za lečenje poremećaja cns-a
|
|
SMT202100113T1
(it)
|
2015-01-26 |
2021-05-07 |
Sage Therapeutics Inc |
Composizioni e metodi per trattare disturbi del snc
|
|
EP3258939B1
(en)
|
2015-02-20 |
2022-09-07 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
BR112018000129B1
(pt)
|
2015-07-06 |
2024-01-09 |
Sage Therapeutics, Inc |
Compostos oxiesteróis, seus usos e composição farmacêutica
|
|
JP6882996B2
(ja)
|
2015-07-06 |
2021-06-02 |
セージ セラピューティクス， インコーポレイテッド |
オキシステロールおよびそれらの使用の方法
|
|
SMT202100476T1
(it)
|
2015-07-06 |
2021-09-14 |
Sage Therapeutics Inc |
Ossisteroli e metodi di uso degli stessi
|
|
CN113616661A
(zh)
|
2016-03-08 |
2021-11-09 |
萨奇治疗股份有限公司 |
神经活性类固醇、其组合物及用途
|
|
SI3436022T1
(sl)
|
2016-04-01 |
2022-08-31 |
Sage Therapeutics, Inc. |
Oksisteroli in postopki za uporabo le-teh
|
|
WO2017193046A1
(en)
|
2016-05-06 |
2017-11-09 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
ES2884071T3
(es)
|
2016-07-07 |
2021-12-10 |
Sage Therapeutics Inc |
24-hidroxiesteroles sustituidos en 11 para el tratamiento de afecciones relacionadas con NMDA
|
|
AU2017296295B2
(en)
|
2016-07-11 |
2022-02-24 |
Sage Therapeutics, Inc. |
C7, C12, and C16 substituted neuroactive steroids and their methods of use
|
|
MA45599A
(fr)
*
|
2016-07-11 |
2019-05-15 |
Sage Therapeutics Inc |
Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
|
|
JOP20190022B1
(ar)
|
2016-08-23 |
2023-03-28 |
Sage Therapeutics Inc |
ستيرويد 19- نور c3، 3- به استبدال ثنائي لـ c21-n بيرازوليل بلوري
|
|
MX392270B
(es)
|
2016-09-30 |
2025-03-24 |
Sage Therapeutics Inc |
Oxisteroles sustituidos en c7 y metodos de uso de los mismos.
|
|
EP4105223B1
(en)
|
2016-10-18 |
2025-04-30 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
CN110267966B
(zh)
|
2016-10-18 |
2022-07-08 |
萨奇治疗股份有限公司 |
氧甾醇及其使用方法
|
|
MX2020008422A
(es)
*
|
2018-02-11 |
2020-09-21 |
Jiangsu Hansoh Pharmaceutical Group Co Ltd |
Regulador derivado de esteroides, metodo para prepararlos y usos de los mismos.
|
|
CN114085260B
(zh)
|
2018-02-11 |
2023-10-20 |
江苏豪森药业集团有限公司 |
甾族类衍生物调节剂、其制备方法和应用
|
|
AR119047A1
(es)
|
2019-05-31 |
2021-11-17 |
Sage Therapeutics Inc |
Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc
|
|
US12215126B2
(en)
*
|
2020-05-21 |
2025-02-04 |
Brigham Young University |
Cationic steroidal antimicrobial compounds with endogenous groups
|
|
WO2023060067A1
(en)
|
2021-10-04 |
2023-04-13 |
Marinus Pharmaceuticals, Inc. |
Amorphous solid dispersion ganaxolone formulation
|